Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Obesity associated with hypothalamic injury

The number of people who suffer from one or more of the adverse complications of obesity, including type 2 diabetes and heart disease is rapidly increasing. Thus far, drugs designed to treat obesity have shown limited efficacy and have been associated with serious side effects.

28 Dec 2011

Working patterns should now be considered a specific risk factor for obesity, type 2 diabetes

The poor diet of shift workers should be considered a new occupational health hazard, according to an editorial published in this month's PLoS Medicine.

28 Dec 2011

FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.

26 Dec 2011

Simple online calculator can tackle pancreatic and bowel cancer

A simple online calculator could offer family GPs a powerful new tool in tackling two of the most deadly forms of cancer, say researchers.

15 Dec 2011

Isis announces addition of three new drug development candidates

Isis Pharmaceuticals, Inc. announced today that it has added three new drugs to its development pipeline, ISIS-APOARx, ISIS-DGAT2Rx and ISIS-FVIIRx.

15 Dec 2011

Thousands of diabetes-related deaths could be avoided with better care: UK Report

According to a new report up to 24,000 diabetes-related deaths could be avoided in England each year, if patients and doctors better managed the condition. This is the first-ever audit of patient deaths from diabetes. It says that basic health checks, a good diet and regular medication could prevent most of the deaths.

15 Dec 2011

New study: Insulin signaling is altered in human pancreas

Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells - the cells that produce insulin.

14 Dec 2011

JDRF initiates enrollment in metformin clinical study for type 1 diabetes

JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes (T1D) in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people with T1D.

14 Dec 2011

Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Aestus Therapeutics, Inc. today reported positive results from a Phase II clinical study evaluating the efficacy of its novel neuropathic pain therapeutic, ATx08-001, in the treatment of post-herpetic neuralgia.

14 Dec 2011

High-intensity intermittent exercise lowers blood sugar levels in type 2 diabetics

Researchers at McMaster University have found that brief high intensity workouts, as little as six sessions over two weeks, rapidly lower blood sugar levels in type 2 diabetics, offering a potential fix for patients who struggle to meet exercise guidelines.

13 Dec 2011

U of A creates 'conversation cards' for pediatric weight management

Medical researchers at the University of Alberta have created a deck of cards with conversation starters about sensitive and informational topics related to weight, that parents can use to guide their discussions when talking about their child's weight management with health professionals.

13 Dec 2011

Low-volume high-intensity exercise training may help treat type 2 diabetes

Regular exercise has proven benefits in preventing and treating type 2 diabetes, but many patients find it tough to meet the American Diabetes Association guidelines of 150 minutes of moderate to vigorous exercise a week.

13 Dec 2011

New nutrition guidelines for healthier living

Figures reveal that more than one third of an average Australian’s diet is made up of fast food that is energy rich but nutrient poor foods and sugary drinks. This is coupled with 62% Australian adults and 25 per cent of children and adolescents being clinically obese. Well balanced nutrition can reduce health risks and only an apple a day can save up to $55m a year in health costs.

12 Dec 2011

Reata, Abbott partner to develop and commercialize AIMs for chronic diseases

Abbott and Reata Pharmaceuticals today announced that they have entered into a worldwide collaboration to jointly develop and commercialize Reata's portfolio of second-generation oral antioxidant inflammation modulators.

12 Dec 2011

Rare genetic condition provides insight into how pancreas develops

A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'programme' stem cells - master cells in the body that can develop into specialised cells - to become pancreatic cells.

12 Dec 2011

State roundup: Consumers dispute Iowa rate hike; Wis. senior program extension?; Fla. criticized on nursing homes

California Pacific Medical Center, including its St. Luke's campus, is San Francisco's most profitable hospital, yet it spends proportionately far less on care for poor residents than other private nonprofit hospitals in the city, according to a new report.

9 Dec 2011

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

VIVUS, Inc. today announced that results from the SEQUEL study were published in The American Journal of Clinical Nutrition, a peer-reviewed journal with broad, multidisciplinary readership.

9 Dec 2011

Positive results from Metabolex arhalofenate plus febuxostat study on hyperuricemia, gout

Metabolex announced positive results from its clinical study of arhalofenate in combination with febuxostat. A key goal in the treatment of gout is to address the patient's underlying hyperuricemia by treatment with drugs that lower serum uric acid.

9 Dec 2011

USPTO issues Diabetes Patent to Omni Bio

Omni Bio Pharmaceutical, Inc. today announced that U.S. Patent No. 8,071,551, entitled "METHODS AND COMPOSITIONS FOR TREATING DIABETES," was issued by the United States Patent and Trademark Office on December 6, 2011. The Diabetes Patent expires in May 2022.

9 Dec 2011

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx, Inc. today announced the initiation of a Phase II clinical trial for CCX140, an orally-administered small molecule for the treatment of diabetic kidney disease.

9 Dec 2011